Is Grey Matters Health Inc. (AGNPF) a Buy, Sell, or Hold?
OTC : AGNPF
Grey Matters Health Inc.
$0.3098 USD
$0.04 (12.74%)
- Volume
- 2K
- Average Volume
- 11.77K
- Market Capitalization
- $1.68M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $0.64
- Year Low
- $0.22
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
Company Overview
OTC
Christopher J. Moreau
Biotechnology
Healthcare
AGNPF
5
CA
USD
Liquidity Metrics
Sales & Valuation
-$
Profitability
-$0.582
-$1.72M
%
%
%
%
P/E Metrics
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-9.60
2/9
-$2.44M
$5.28M
$3.52M
-$1.58M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Christopher Bryan | Vice President of Research & Operations |
| Paul Moreau | Chief Marketing & Communications Officer |
| Christopher J. Moreau | Chief Executive Officer & Director |
| James F. Kinley | Chief Financial Officer & Corporate Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Grey Matters Health Inc. (OTC:AGNPF) Stock
Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada. ...
2026-08-04 07:00:00
VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it plans to open its flagship NovaScan Neuroimaging ClinicsTM location next month in Davie, Florida and conduct a brain PET scan of its first patient by September 30th, 2026.
2026-07-06 07:00:00
VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.
2026-06-18 07:00:00
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce an increase to its non-brokered private placement (the “Offering”), previously announced on April 22, 2026 and updated on May 25, 2026 and June 5, 2026 to $1,250,000 and the closing of the second and final tranche (the “Second Tranche”). Gross proceeds from the Second Tranche totalled CAD $750,000 from the sale of 1,875,000 units (the “Units”) at an issue price of CAD $0.40 per Unit.
Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing
2026-06-05 16:01:00
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 05, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce the closing of the first tranche (the “First Tranche”) of its non-brokered private placement (the “ Offering”), previously announced on April 22, 2026 and updated on May 25, 2026. Gross proceeds from the First Tranche totalled CAD $500,000 from the sale of 1,250,000 units (the “Units”) at an issue price of CAD $0.40 per Unit.
Grey Matters Improves Warrant Terms of Private Placement
2026-05-25 07:00:00
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 25, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has amended the warrant terms of its recently announced non-brokered private placement, removing the acceleration feature and extending the warrant exercise period to 3 years. All other terms remain unchanged.
Grey Matters Improves Warrant Terms of Private Placement
2026-05-25 07:00:00
NOT FOR DISTRIBUTION TO U. S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 25, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the "Company" or "Grey Matters") (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has amended the warrant terms of its recently announced non-brokered private placement, removing the acceleration feature and extending the warrant exercise period to 3 years.
2026-05-20 07:00:00
VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer's Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company's NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida.
Frequently Asked Questions
-
What is the current Grey Matters Health Inc. (AGNPF) stock price?
-
Grey Matters Health Inc.(OTC:AGNPF) stock price is $0.3098 in the last trading session. During the trading session, AGNPF stock reached the peak price of $0.64 while $0.2183 was the lowest point it dropped to. The percentage change in AGNPF stock occurred in the recent session was 12.74% while the dollar amount for the price change in AGNPF stock was $0.04.
-
AGNPF's industry and sector of operation?
-
The OTC listed AGNPF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of AGNPF?
-
Christopher Bryan | Vice President of Research & Operations
Paul Moreau | Chief Marketing & Communications Officer
Christopher J. Moreau | Chief Executive Officer & Director
James F. Kinley | Chief Financial Officer & Corporate Secretary
| -
How many employees does AGNPF have?
-
Number of AGNPF employees currently stands at 5. AGNPF operates from 601 West Broadway, Vancouver, BC V5Z 4C2, CA.
-
Link for AGNPF official website?
-
Official Website of AGNPF is: https://www.greymatters-health.com
-
How do I contact AGNPF?
-
AGNPF could be contacted at phone #+1 604 398 4175 and can also be accessed through its website. AGNPF operates from 601 West Broadway, Vancouver, BC V5Z 4C2, CA.
-
How many shares of AGNPF are traded daily?
-
The average number of AGNPF shares traded daily for last 3 months was 11.77K.
-
What is the market cap of AGNPF currently?
-
The market value of AGNPF currently stands at $1.68M with its latest stock price at $0.3098